These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 36855845

  • 1. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Vasilev P, Kalev D, Karamanliev M, Dimitrov D, Troyanova P, Yordanova I.
    J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845
    [No Abstract] [Full Text] [Related]

  • 2. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.
    Kim M, Li M, Intong LR, Tran K, Melbourne W, Marucci D, Bucci J, de Souza P, Mallesara G, Murrell DF.
    Br J Dermatol; 2013 Jul; 169(1):208-10. PubMed ID: 23398414
    [No Abstract] [Full Text] [Related]

  • 3. Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Reimer A, Lu S, He Y, Bruckner-Tuderman L, Technau-Hafsi K, Meiss F, Has C, von Bubnoff D.
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e1-e3. PubMed ID: 31374134
    [No Abstract] [Full Text] [Related]

  • 4. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
    Weber F, Bauer JW, Sepp N, Högler W, Salmhofer W, Hintner H, Fritsch P.
    Acta Derm Venereol; 2001 Jan; 81(3):189-92. PubMed ID: 11558875
    [Abstract] [Full Text] [Related]

  • 5. Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.
    Ciurescu D, Condruz S, Irimie M.
    Acta Dermatovenerol Alp Pannonica Adriat; 2024 Sep; 33(3):145-149. PubMed ID: 38808531
    [Abstract] [Full Text] [Related]

  • 6. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
    Shivaswamy KN, Sumathy TK, Shyamprasad AL, Ranganathan C.
    Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
    [Abstract] [Full Text] [Related]

  • 7. Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.
    Medek K, Koelblinger P, Koller J, Diem A, Ude-Schoder K, Bauer JW, Laimer M.
    J Dtsch Dermatol Ges; 2019 Apr; 17(4):448-450. PubMed ID: 30821421
    [No Abstract] [Full Text] [Related]

  • 8. Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis Bullosa.
    Piccerillo A, El Hachem M, De Vito R, De Luca EV, Peris K.
    JAMA Dermatol; 2020 Jun 01; 156(6):708-710. PubMed ID: 32320041
    [No Abstract] [Full Text] [Related]

  • 9. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].
    Fourel E, Claudy AL.
    Ann Dermatol Venereol; 1992 Jun 01; 119(8):563-5. PubMed ID: 1485760
    [Abstract] [Full Text] [Related]

  • 10. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.
    Csikós M, Orosz Z, Bottlik G, Szöcs H, Szalai Z, Rozgonyi Z, Hársing J, Török E, Bruckner-Tuderman L, Horváth A, Kárpáti S.
    Clin Exp Dermatol; 2003 Mar 01; 28(2):163-6. PubMed ID: 12653705
    [Abstract] [Full Text] [Related]

  • 11. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
    Newman C, Wagner RF, Tyring SK, Spigel GT.
    J Dermatol Surg Oncol; 1992 Apr 01; 18(4):301-5. PubMed ID: 1560154
    [Abstract] [Full Text] [Related]

  • 12. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
    Yamada M, Hatta N, Sogo K, Komura K, Hamaguchi Y, Takehara K.
    Dermatol Surg; 2004 Nov 01; 30(11):1424-9. PubMed ID: 15522026
    [Abstract] [Full Text] [Related]

  • 13. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP, O'Toole EA.
    Dermatol Clin; 2010 Jan 01; 28(1):171-8. PubMed ID: 19945632
    [Abstract] [Full Text] [Related]

  • 14. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
    Ayman T, Yerebakan O, Ciftçioglu MA, Alpsoy E.
    Pediatr Dermatol; 2002 Jan 01; 19(5):436-8. PubMed ID: 12383103
    [Abstract] [Full Text] [Related]

  • 15. Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
    Jacków J, Rami A, Hayashi R, Hansen C, Guo Z, DeLorenzo D, Pappalardo A, Alvarez Cespedes D, Kim AL, Perez-Lorenzo R, Owens DM, Christiano AM.
    J Invest Dermatol; 2021 Apr 01; 141(4):942-946. PubMed ID: 33069729
    [No Abstract] [Full Text] [Related]

  • 16. Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient.
    Xará J, Relvas M, Figueiredo C, Calvão J, Batista M, Ramos L.
    Int J Dermatol; 2023 Dec 01; 62(12):e617-e618. PubMed ID: 37622659
    [No Abstract] [Full Text] [Related]

  • 17. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient.
    Tomita Y, Sato-Matsumura KC, Sawamura D, Matsumura T, Shimizu H.
    Acta Derm Venereol; 2003 Dec 01; 83(3):225-6. PubMed ID: 12816163
    [No Abstract] [Full Text] [Related]

  • 18. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Rodeck U, Fertala A, Uitto J.
    Exp Dermatol; 2007 Jun 01; 16(6):465-7. PubMed ID: 17518985
    [Abstract] [Full Text] [Related]

  • 19. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
    Dammak A, Zribi J, Boudaya S, Mseddi M, Meziou TJ, Masmoudi A, Ellouze Z, Keskes H, Turki H.
    Int J Dermatol; 2009 Jun 01; 48(6):588-91. PubMed ID: 19538366
    [Abstract] [Full Text] [Related]

  • 20. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH.
    Dermatology; 2009 Jun 01; 219(1):80-3. PubMed ID: 19439919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.